drugs fall 2014_ppt

Upload: ashleynorris1403

Post on 02-Jun-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/10/2019 Drugs Fall 2014_ppt

    1/31

    DRUGS FALL 2014

    Pharm List

  • 8/10/2019 Drugs Fall 2014_ppt

    2/31

    ACETAMINOPHEN (TYLENOL)-NON-NS

    Drug class: non-opiod analgesic, antipyretic

    Mechanism of action: blocks peripheral pain stimuli by inhibiting prostagdirect action on hypothalmus to reduce body temperature

    Adult dose: 650-1000 mg by mouth or PR every 6 hours as needed for pa

    Infants: dose dependent on age/ weight; given by mouth

    Antipyretic of choice in infants and children

  • 8/10/2019 Drugs Fall 2014_ppt

    3/31

    ACETAMINOPHEN (TYLENOL)-NON-NS

    Indications: mild to moderate pain, fever

    Contraindications: allergy, severe liver disease, genetic G6PD deficiency

    Pregnancy and breast feeding: Category B

    Crosses placenta and breast milk; no adequate, well controlled studies

    Adverse effects (rare): rash, nausea, vomiting

    Drug interactions: other hepatotoxic drugs, alcohol

  • 8/10/2019 Drugs Fall 2014_ppt

    4/31

    ACETAMINOPHEN (TYLENOL)-NON-NS

    Toxicity and overdose: Adults should NOT take more than 3000 mg daily

    Liver necrosis, kidney problems

    Blood test for acetaminophen level

    Half life: 1-4 hours

    Onset of action: 10-30 minutes Peak: 30 min -2 hours

    Duration: 3-4 hours

  • 8/10/2019 Drugs Fall 2014_ppt

    5/31

    ACETAMINOPHEN (TYLENOL)-NON-NS

    Antidote for OD: acetylcysteine (Mucomyst) Prevents hepatic metabolites from forming

    Loading dose of 140 mg/kg by mouth

    70mg/ kg every four hours for a total of 17 doses

    If the patient vomits within an hour of a dose, then the dose should be re

  • 8/10/2019 Drugs Fall 2014_ppt

    6/31

    ACETYLSALICYLIC ACID (ASPIRIN)-NSA

    Drug class: salicylate (acetylated NSAID), antipyretic, prophylaxis againsdisease and stroke

    Mechanism of action: block prostaglandins that contribute to inflammatand fever

    Adult dose: 81- 325 mg daily to prevent heart disease, 650 mg every fourpain or fever

    Infants and Children: associated with progressive neurological deficits lecoma- Reyes syndrome. Only recommended for adults

  • 8/10/2019 Drugs Fall 2014_ppt

    7/31

    ACETYLSALICYLIC ACID (ASPIRIN)-NSA

    Indications: mild to moderate pain, inflammation, fever

    Contraindications: drug allergy, bleeding problems, pregnancy, renal or hdisease

    Adverse effects: heartburn, stomach upset, gastrointestinal bleeding

    Drug interactions: Alcohol and anticoagulants increase risk of bleeding, d

    bind protein (dilantin) amy increase therapeutic response, NSAIDS may effectiveness of diuretics (water pills)

  • 8/10/2019 Drugs Fall 2014_ppt

    8/31

    ACETYLSALICYLIC ACID (ASPIRIN)-NSA

    Nursing implications: take with food, monitor for bleeding

    Half life: 5-9 hours

    Onset of action: 15-30 minutes

    Peak: 45 minutes to 3 hours

    Duration: 3-4 hours

  • 8/10/2019 Drugs Fall 2014_ppt

    9/31

    ACETYLSALICYLIC ACID (ASPIRIN)-NSA

    Pregnancy Category C (first and 2ndtrimester: adverse effect on animal fevaluate risks/benefits), D (3rdtrimester): dont use Salicylate (aspirin) to

    Chronic salicylate intoxication

    Symptoms: increased pulse, tinnitus, hearing loss, poor vision, dizziness, menconfusion, weakness (lassitude), drowsiness, sweating, thirst, breathing fast (normalize blood pH), high or low blood sugar, low blood pressure

    Metabolic acidosis Acute salicylate toxicity

    From a single large dose

    Same as above, but happens acutely

  • 8/10/2019 Drugs Fall 2014_ppt

    10/31

    ACETYLSALICYLIC ACID (ASPIRIN)-NSA

    Salicylate level Treatment of Salicylate (aspirin) toxicity

    Treatment goals: reduce absorbtion (charcoal, lavage)

    Treat fluid and electrolyte imbalance

    Metabolic acidosis

    Support blood pressure with IV fluids

    Support breathing (may need ventilator)

    Hemodialysis

  • 8/10/2019 Drugs Fall 2014_ppt

    11/31

    IBUPROFEN (MOTRIN, ADVIL)-NSAID

    Drug class: nonsalicylate NSAID, antipyretic

    Mechanism of action: same as aspirin

    Indications: mild to moderate pain, inflammation, fever

    Pregnancy Category B (D in third trimester)

    Contraindications: drug allergy, bleeding problems, pregnancy, renal or hdisease

    Adverse effects: heartburn, stomach upset, gastrointestinal bleeding, inccardiovascular risk, renal failure

  • 8/10/2019 Drugs Fall 2014_ppt

    12/31

    IBUPROFEN (MOTRIN, ADVIL)-NSAID

    Drug interactions: Alcohol and anticoagulants increase risk of bleeding, dbind protein (dilantin) may increase therapeutic response, NSAIDS may effectiveness of diuretics (water pills)

    Pregnancy category: B (1st2 trimesters), D (3rdtrimester)

    Nursing implications: take with food, monitor kidney function, monitor fbleeding

    Half life: less than 30 minutes

    Onset: 30 minutes to 2 hours

    Peak: 1-2 hours

    Duration: 4-6 hours

  • 8/10/2019 Drugs Fall 2014_ppt

    13/31

    IBUPROFEN (MOTRIN, ADVIL)-NSAID

    The dose range is: Adult dose: 1200-3200 mg daily in 3 or 4 divided doses

    Infants and Children: 20-40 mg/kg/day in 3 or 4 divided doses

    Acute overdose nonsalicylate NSAID

    Symptoms: headache, tinnitis, lethargy, confusion, paresthesias, numbnseizures, nausea, vomiting, gastrointestinal bleeding, cardiac arrest

    Treatment: removal of the drug by inducing emesis with gastric lavage, gactivated charcoal, support symptoms

    Unlike aspirin, hemodialysis will not remove the drug from the body com

  • 8/10/2019 Drugs Fall 2014_ppt

    14/31

  • 8/10/2019 Drugs Fall 2014_ppt

    15/31

    FUROSEMIDE (LASIX)

    Distribution: Crosses placenta; enters breast milk

    Dose Depends On:

    Condition being treated

    Size and age of the patient

    Route of administration

    Dose: Average Adult Dose po 20-80 mg/day Average Adult Dose IV 20-40 mg

    Average Pediatric Dose po, IM, IV 2mg/kg*

  • 8/10/2019 Drugs Fall 2014_ppt

    16/31

    FUROSEMIDE (LASIX)

    Reactions: Rash, Pruritus

    Orthostatic hypotension-Hearing loss

    Electrolyte imbalances-Hyperglycemia

    Nausea, vomiting, Anorexia

    Diarrhea (NVD)

    Circulatory collapse , Neutropenia

    (Many others are listed in the drug references books.)

  • 8/10/2019 Drugs Fall 2014_ppt

    17/31

    MILK OF MAGNESIA (MAGNESIUM HYDROX

    Onset: 0.5-3 hr

    peak 3 hr

    duration: variable

  • 8/10/2019 Drugs Fall 2014_ppt

    18/31

    SENNA

    onset: 6-24 hr Peak 24 hr

    Duration: 24-36 hr

  • 8/10/2019 Drugs Fall 2014_ppt

    19/31

    BISMUTH SUBSALICYLATE (KAOPECTATE,PEPTO-BISMAL)

    Check with physician before giving to children

    Associated with Reyes syndrome

    Onset: 0.5-2hr

    Peak: 2-5 hr

    Duration and half life variable

    May cause black stool

  • 8/10/2019 Drugs Fall 2014_ppt

    20/31

    LOPERAMIDE (IMMODIUM A-D)

    Drug class: anticholinergic Action: inhibits peristalsis and reduces intestinal secretion

    Reduces number of stools and water content

    Contraindications: ulcerative colitis, pseudomembranous colitis, infectious diar

    Half life:7-15 hrs

    Onset: 1-3 hrs

    Peak: 4 hrs

    Duration: 40-50 hrs

    Pregnancy Category B

  • 8/10/2019 Drugs Fall 2014_ppt

    21/31

    DOCUSATE SODIUM (COLACE)

    Onset and duration: 1-3 days Peak: unknown Pregnancy category C

  • 8/10/2019 Drugs Fall 2014_ppt

    22/31

    BARBITURATES

    First introduced into clinical use in 1903

    Prescribed for sedative, hypnotic, and antiseizureffects & was mainstay of treatment for anxiety insomnia

    Now rarely prescribed for anxiety and insomnia due to side effects and a

    of more effective medications Chemically they are derivatives of barbituric acid

    They are habit forming and have a narrow therapeutic index

  • 8/10/2019 Drugs Fall 2014_ppt

    23/31

    BARBITURATES

    Drug Effects:

    In low doses, acts as sedative.

    Increasing the dose produces hypnotic effect decreasingrespiratory rate

    Stimulate enzymes in liver responsible for metabolism of drugsdrugs have faster onset of action and shof effect.

    Side Effects/Adverse Effects

    Main side effects affect CNS Drowsiness

    Lethargy

    Dizziness

    Hangover

    Paradoxical restlessness or excitement

    Chronic effects on sleep architecture can be detrimental d/t decreased REM sleewithdrawal causes nightmares d/t increased REM with rebound effect

  • 8/10/2019 Drugs Fall 2014_ppt

    24/31

    BARBITURATES

    Toxicity: Respiratory depression

    Intentional overdoses

    Phenobarbital coma

    CNS depression ranging from sleep to profound coma and death

    Respiratory depressions progresses to hypoventilation and cyanosisSigns of OD

    Cold, clammy skin, may be hypothermic

    Later can exhibit fever, areflexia, tachycardia, and hypotension

    Pupils usually slightly constricted, but may be dilated in the event of severe pois

  • 8/10/2019 Drugs Fall 2014_ppt

    25/31

    BENZODIAZEPINES

    Most frequently prescribed sedative-hypnotic agents and one of thcommonly prescribed classes of drugs.

    Favorable side effect profiles, efficacy, and safety.

    Classified as anxiolytic or sedative-hypnotic, depending on primary

    All 15 have same side effects and adverse reactions

    Produce considerably less physical dependence and result in less tothan barbiturates

    May be abused recreationally

  • 8/10/2019 Drugs Fall 2014_ppt

    26/31

    BENZODIAZEPINES: SEDATIVE-HYPNO

  • 8/10/2019 Drugs Fall 2014_ppt

    27/31

    BENZODIAZEPINES

    Action Bind to GABA, a natural inhibitory neurotransmitter in brain

    Metabolized in liver to active metabolites and excreted primarily in urine

    Do NOT produce life-threatening respiratory depression or coma in excessive amouhowever, will still cause rapid CNS and respiratory depression when given IV- monito

    Indications:

    Drug of choice for short term treatment of insomnia caused by anx Shorten length of time to fall asleep

    Reduce frequency of interrupted sleep

    Increase total sleep time, but reduce stage 4 and some REM

  • 8/10/2019 Drugs Fall 2014_ppt

    28/31

    BENZODIAZEPINES

    Nursing Considerations:

    Monitor condition and provide education

    Assess symptoms and need for medication

    Use with caution if suicidal or has sleep apnea

    Contraindicated in narrow-angle glaucoma & organic brain disease

    Use cautiously in presence of

    Liver or renal impairment Impaired respiratory function

    Pregnancy category D Not recommended for pregnant or nursing moms

    Crosses placenta and excreted in breast milk

  • 8/10/2019 Drugs Fall 2014_ppt

    29/31

    BENZODIAZEPINES

    Side Effects Drowsiness

    Dizziness

    Risk for injury

    For overdose, Flumazenil (Romazicon) used to acutely reverse effe

    competes for binding at receptor sites

  • 8/10/2019 Drugs Fall 2014_ppt

    30/31

    MUSCULOSKELETAL RELAXANTS

    Most are central-acting: All central-acting have potential to casedation

    Mechanism of action not fully known

    Believed to inhibit upper motor neuron activity

    Causes sedation

    Alters simple reflexes

    Most effective in conjunction with rest and physical thera

    Enhanced CNS depression results from co-ingestion of ETopioids, or other CNS depressants

  • 8/10/2019 Drugs Fall 2014_ppt

    31/31

    MUSCULOSKELETAL RELAXANTS

    Nursing Considerations:

    Assess Food and drug allergies

    Contraindicated if hypersensitive to protein-based foods

    History of uncontrolled hypertension Drug can raise BP to dangerously high levels

    Vital signs

    Baseline lab tests Especially CBC

    Use with caution in pregnant and lactating women (pregnancy category C)

    Monitor for early signs of heart attack or stroke Increases risk of thromboembolic disease

    May need increased doses of heparin

    Monitor for side effects of nausea, vomiting, constipation, medication site reaction, & headac